NO20052149L - Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein. - Google Patents
Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein.Info
- Publication number
- NO20052149L NO20052149L NO20052149A NO20052149A NO20052149L NO 20052149 L NO20052149 L NO 20052149L NO 20052149 A NO20052149 A NO 20052149A NO 20052149 A NO20052149 A NO 20052149A NO 20052149 L NO20052149 L NO 20052149L
- Authority
- NO
- Norway
- Prior art keywords
- hcv
- sequence encoding
- protein
- polynucleotide sequence
- virus protein
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 6
- 108090000623 proteins and genes Proteins 0.000 title abstract 5
- 102000004169 proteins and genes Human genes 0.000 title abstract 5
- 108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 title 1
- 102000040430 polynucleotide Human genes 0.000 abstract 3
- 108091033319 polynucleotide Proteins 0.000 abstract 3
- 239000002157 polynucleotide Substances 0.000 abstract 3
- 101710132601 Capsid protein Proteins 0.000 abstract 2
- 108010041986 DNA Vaccines Proteins 0.000 abstract 1
- 229940021995 DNA vaccine Drugs 0.000 abstract 1
- 108700039791 Hepatitis C virus nucleocapsid Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/89—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection
- C12N15/895—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microinjection using biolistic methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0226722.7A GB0226722D0 (en) | 2002-11-15 | 2002-11-15 | Vaccine |
| PCT/EP2003/012793 WO2004046175A1 (en) | 2002-11-15 | 2003-11-13 | Vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20052149D0 NO20052149D0 (no) | 2005-05-02 |
| NO20052149L true NO20052149L (no) | 2005-07-11 |
Family
ID=9947928
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052149A NO20052149L (no) | 2002-11-15 | 2005-05-02 | Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein. |
| NO20052136A NO20052136L (no) | 2002-11-15 | 2005-05-02 | Vaksine mot Hepatitt C-virus (HCV). |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20052136A NO20052136L (no) | 2002-11-15 | 2005-05-02 | Vaksine mot Hepatitt C-virus (HCV). |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US20060246090A1 (ja) |
| EP (2) | EP1560845A1 (ja) |
| JP (2) | JP2006518331A (ja) |
| KR (2) | KR20050085010A (ja) |
| CN (2) | CN1738833A (ja) |
| AR (1) | AR041964A1 (ja) |
| AU (2) | AU2003288072A1 (ja) |
| BR (2) | BR0316291A (ja) |
| CA (2) | CA2504715A1 (ja) |
| CO (1) | CO5700833A2 (ja) |
| GB (1) | GB0226722D0 (ja) |
| IS (2) | IS7831A (ja) |
| MA (2) | MA27699A1 (ja) |
| MX (2) | MXPA05005203A (ja) |
| NO (2) | NO20052149L (ja) |
| NZ (2) | NZ539998A (ja) |
| PL (2) | PL376967A1 (ja) |
| RU (2) | RU2363492C2 (ja) |
| TW (1) | TW200502246A (ja) |
| WO (2) | WO2004046176A1 (ja) |
| ZA (2) | ZA200503802B (ja) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7022830B2 (en) * | 2000-08-17 | 2006-04-04 | Tripep Ab | Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| GB0226722D0 (en) * | 2002-11-15 | 2002-12-24 | Glaxo Group Ltd | Vaccine |
| US7439042B2 (en) | 2002-12-16 | 2008-10-21 | Globeimmune, Inc. | Yeast-based therapeutic for chronic hepatitis C infection |
| CN101437964B (zh) * | 2004-10-18 | 2012-06-13 | 全球免疫股份有限公司 | 基于酵母的对慢性丙型肝炎感染的治疗 |
| JP5405832B2 (ja) * | 2006-01-04 | 2014-02-05 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド | Ｈｃｖ特異的なｔ細胞の活性化 |
| MX2008011361A (es) * | 2006-03-09 | 2008-09-15 | Transgene Sa | Proteina de fusion no-estructural del virus de hepatitis c. |
| AU2007345768B2 (en) * | 2006-07-27 | 2013-08-01 | Ligocyte Pharmaceuticals, Inc. | Chimeric influenza virus-like particles |
| EP2044224A4 (en) * | 2006-07-27 | 2011-04-13 | Ligocyte Pharmaceuticals Inc | CHIMERIC VIRUS TYPE PARTICLES |
| KR100759106B1 (ko) * | 2007-02-14 | 2007-09-19 | 이화여자대학교 산학협력단 | 초미세 전기기계 시스템 미러에서 미러 판을 정전 구동부와 결합하는 방법 |
| WO2009022236A2 (en) | 2007-08-16 | 2009-02-19 | Tripep Ab | Immunogen platform |
| US9758794B2 (en) | 2008-04-22 | 2017-09-12 | Rutgers, The State University Of New Jersey | HCV E2 construct compositions and methods |
| US20110091495A1 (en) * | 2008-04-22 | 2011-04-21 | Rutgers, The State University Of New Jersey | Hcv e2 construct compositions and methods |
| AU2009273949A1 (en) * | 2008-07-24 | 2010-01-28 | Aduro Biotech | Compositions and methods for the treatment of hepatitis C |
| US8728489B2 (en) | 2008-09-19 | 2014-05-20 | Globeimmune, Inc. | Immunotherapy for chronic hepatitis C virus infection |
| CN101748151B (zh) * | 2008-12-19 | 2012-10-17 | 深圳市源兴生物医药科技有限公司 | 一种重组人丙肝病毒抗原腺病毒载体及其应用 |
| JP2010168288A (ja) * | 2009-01-20 | 2010-08-05 | Yokohama City Univ | 最適化した抗原遺伝子の使用によるウイルスワクチンの免疫原性の増強 |
| JP5917402B2 (ja) | 2009-11-03 | 2016-05-11 | タケダ ヴァクシーンズ， インコーポレイテッド | キメラＲＳＶ−Ｆポリペプチド、およびレンチウイルスＧａｇまたはアルファレトロウイルスＧａｇに基づくＶＬＰ |
| CN102233137B (zh) * | 2010-04-30 | 2013-02-20 | 北京凯因科技股份有限公司 | 一种用于治疗乙型肝炎的重组质粒dna疫苗组合物 |
| US10363293B2 (en) | 2013-02-21 | 2019-07-30 | Turnstone Limited Partnership | Vaccine composition |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6297048B1 (en) * | 1992-02-04 | 2001-10-02 | Chiron Corporation | Hepatitis therapeutics |
| DE69533167D1 (de) * | 1994-10-05 | 2004-07-22 | Apollon Inc | Impfstoffe gegen den hepatitis b und c virus |
| IL118364A0 (en) * | 1995-05-22 | 1996-09-12 | Bionova Corp | A hepatitis C virus-derived composition methods for the preparation thereof and assays for the detection of hepatitis C virus |
| AU717542B2 (en) * | 1996-06-11 | 2000-03-30 | Merck & Co., Inc. | Synthetic hepatitis C genes |
| US7052696B2 (en) * | 1998-07-10 | 2006-05-30 | The United States Of America As Represented By The Department Of Health And Human Services | Antigenic epitopes and mosaic polypeptides of hepatitis C virus proteins |
| EP1200465A1 (en) * | 1999-07-09 | 2002-05-02 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services | Antigenic epitopes and mosaic polypeptides of hepatitis c virus proteins |
| US6562346B1 (en) * | 1999-10-27 | 2003-05-13 | Chiron Corporation | Activation of HCV-specific T cells |
| JP2003516732A (ja) * | 1999-11-24 | 2003-05-20 | カイロン コーポレイション | 新規なｈｃｖ非構造ポリペプチド |
| FI116851B (fi) * | 2001-05-03 | 2006-03-15 | Fit Biotech Oyj Plc | Ilmentämisvektori, sen käyttöjä ja menetelmä sen valmistamiseksi sekä sitä sisältäviä tuotteita |
| GB0226722D0 (en) * | 2002-11-15 | 2002-12-24 | Glaxo Group Ltd | Vaccine |
-
2002
- 2002-11-15 GB GBGB0226722.7A patent/GB0226722D0/en not_active Ceased
-
2003
- 2003-11-13 AU AU2003288072A patent/AU2003288072A1/en not_active Abandoned
- 2003-11-13 CA CA002504715A patent/CA2504715A1/en not_active Abandoned
- 2003-11-13 KR KR1020057008794A patent/KR20050085010A/ko not_active Application Discontinuation
- 2003-11-13 RU RU2005113691/13A patent/RU2363492C2/ru not_active IP Right Cessation
- 2003-11-13 RU RU2005113692/13A patent/RU2323744C2/ru not_active IP Right Cessation
- 2003-11-13 MX MXPA05005203A patent/MXPA05005203A/es not_active Application Discontinuation
- 2003-11-13 EP EP03779952A patent/EP1560845A1/en not_active Withdrawn
- 2003-11-13 KR KR1020057008793A patent/KR20050085009A/ko not_active Application Discontinuation
- 2003-11-13 TW TW092131802A patent/TW200502246A/zh unknown
- 2003-11-13 MX MXPA05005202A patent/MXPA05005202A/es active IP Right Grant
- 2003-11-13 JP JP2004552615A patent/JP2006518331A/ja active Pending
- 2003-11-13 AR ARP030104193A patent/AR041964A1/es unknown
- 2003-11-13 BR BR0316291-5A patent/BR0316291A/pt not_active IP Right Cessation
- 2003-11-13 US US10/535,047 patent/US20060246090A1/en not_active Abandoned
- 2003-11-13 PL PL376967A patent/PL376967A1/pl not_active Application Discontinuation
- 2003-11-13 NZ NZ539998A patent/NZ539998A/en unknown
- 2003-11-13 PL PL376882A patent/PL376882A1/pl not_active Application Discontinuation
- 2003-11-13 JP JP2004552621A patent/JP2006524181A/ja active Pending
- 2003-11-13 BR BR0316244-3A patent/BR0316244A/pt not_active IP Right Cessation
- 2003-11-13 CN CNA200380108865XA patent/CN1738833A/zh active Pending
- 2003-11-13 CA CA002504654A patent/CA2504654A1/en not_active Abandoned
- 2003-11-13 AU AU2003288084A patent/AU2003288084A1/en not_active Abandoned
- 2003-11-13 CN CNA2003801088698A patent/CN1738834A/zh active Pending
- 2003-11-13 US US10/534,774 patent/US20060135451A1/en not_active Abandoned
- 2003-11-13 NZ NZ539999A patent/NZ539999A/en unknown
- 2003-11-13 EP EP03779938A patent/EP1560844A1/en not_active Withdrawn
- 2003-11-13 WO PCT/EP2003/012830 patent/WO2004046176A1/en active Application Filing
- 2003-11-13 WO PCT/EP2003/012793 patent/WO2004046175A1/en active Application Filing
-
2005
- 2005-04-28 IS IS7831A patent/IS7831A/is unknown
- 2005-04-28 IS IS7830A patent/IS7830A/is unknown
- 2005-05-02 NO NO20052149A patent/NO20052149L/no not_active Application Discontinuation
- 2005-05-02 NO NO20052136A patent/NO20052136L/no not_active Application Discontinuation
- 2005-05-11 ZA ZA200503802A patent/ZA200503802B/en unknown
- 2005-05-11 ZA ZA200503803A patent/ZA200503803B/en unknown
- 2005-05-16 MA MA28284A patent/MA27699A1/fr unknown
- 2005-05-16 MA MA28285A patent/MA27700A1/fr unknown
- 2005-06-10 CO CO05056623A patent/CO5700833A2/es not_active Application Discontinuation
-
2008
- 2008-07-17 US US12/174,715 patent/US20090104231A1/en not_active Abandoned
-
2009
- 2009-05-26 US US12/471,772 patent/US20090232847A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20052149L (no) | Polynukleotidvaksine omfattende sekvens som koder for hepatitt C-virus protein. | |
| Enjuanes et al. | Molecular basis of coronavirus virulence and vaccine development | |
| Totura et al. | Broad-spectrum coronavirus antiviral drug discovery | |
| Li et al. | Highly pathogenic avian influenza A (H5N8) virus in wild migratory birds, Qinghai Lake, China | |
| Belliot et al. | In vitro proteolytic processing of the MD145 norovirus ORF1 nonstructural polyprotein yields stable precursors and products similar to those detected in calicivirus-infected cells | |
| Shirato et al. | Viral envelope protein glycosylation is a molecular determinant of the neuroinvasiveness of the New York strain of West Nile virus | |
| Patterson et al. | Epidemiology and pathogenesis of Bolivian hemorrhagic fever | |
| NO20052071L (no) | Bezofuranforbindelser, preparater og metoder for behandling og forebygging av hepatitt C virale infeksjoner og relaterte sykdommer. | |
| Chaturvedi et al. | Identification of a therapeutic interfering particle—A single-dose SARS-CoV-2 antiviral intervention with a high barrier to resistance | |
| NO20054608L (no) | Influensavirusvaksine | |
| ATE499442T1 (de) | Modifizierte genomische rna des menschlichen hepatitis-c-virus mit autonomer replikationskompetenz | |
| NO20044941L (no) | Modifisert vacciniavirus Ankara til vaksinasjon av nyfodte | |
| PT1335987E (pt) | Variante do virus vacina modificado ancara | |
| CO6210761A2 (es) | Vectores de virus oncoliticos de viruela | |
| Darweesh et al. | Characterization of the cytopathic BVDV strains isolated from 13 mucosal disease cases arising in a cattle herd | |
| MXPA02011545A (es) | Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela. | |
| BR112022016992A2 (pt) | Vacina com base em poxvírus recombinante contra ví-rus sars-cov-2 | |
| AR094725A1 (es) | Parvovirus 5a porcino, métodos de uso y vacuna | |
| Lattwein et al. | Pestivirus virion morphogenesis in the absence of uncleaved nonstructural protein 2-3 | |
| MX2023000041A (es) | Composiciones y metodos para inducir una respuesta inmunitaria contra coronavirus. | |
| Woo et al. | A novel dromedary camel enterovirus in the family Picornaviridae from dromedaries in the Middle East | |
| Vilček et al. | Cellular insertions in the NS2-3 genome region of cytopathic bovine viral diarrhoea virus (BVDV) isolates | |
| Taylor | Obstacles and advances in SARS vaccine development | |
| NO20065765L (no) | Heart and skeletal muscle inflammation (HSMI) virus | |
| HK1130664A1 (en) | Hepatitis c virus non structural fusion protein |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |